# Mild Alzheimer's patients benefit from 40Hz sensory stimulation in national clinical trial

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-mild-alzheimer-patients-benefit-40hz.html) · 2026-11-18 · Medicine
Page: https://themorning.science/story/mild-alzheimer-s-patients-benefit-from-40hz-sensory-stimulation-in-national-clin-a357da44e26a47ae
Kind: research · Impact: medium

## In brief

- Cognito Therapeutics announced the results of its pivotal clinical trial in mild Alzheimer's patients on November 16 at the Clinical Trials on Alzheimer's Disease conference in Boston.
- The trial tested a noninvasive, device-based approach using 40Hz sensory stimulation, a technique first discovered at the Picower Institute. The provided sources do not give the trial's efficacy figures.

## Why it matters

It reports pivotal-trial results for a noninvasive, device-based Alzheimer's treatment, a different category from drug therapies, so its outcomes will matter to researchers evaluating non-drug interventions.

## Timeline

- 2026-11-16: Cognito Therapeutics announced pivotal clinical trial results at the Clinical Trials on Alzheimer's Disease conference in Boston

## Coverage

- [Mild Alzheimer's patients benefit from 40Hz sensory stimulation in national clinical trial](https://medicalxpress.com/news/2026-11-mild-alzheimer-patients-benefit-40hz.html) — Medical Xpress - latest medical and health news stories, 2026-11-18

Tags: alzheimer, clinical trial, gamma stimulation, neuroscience, medical device

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
